TRANSITION THERAPEUTICS

Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition's lead products include ELND005 for the treatment of Alzheimer's disease and TT223 for the treatment of diabetes. Transition has an emerging pipeline of preclinical drug candidates acquired externally and developed internally using its proprietary drug discovery engine.

#People #Financial #Website #More

TRANSITION THERAPEUTICS

Industry:

Biopharma Biotechnology Therapeutics

Founded:

1987-01-01

Address:

Toronto, Ontario, Canada

Country:

Canada

Website Url:

http://www.transitiontherapeutics.com

Total Employee:

11+

Status:

Closed

Contact:

416-260-7770

Email Addresses:

[email protected]

Total Funding:

41.8 M USD

Technology used in webpage:

SPF Network Solutions DNS AppRiver

Current Employees Featured

not_available_image

Bruce Connop
Bruce Connop Vice President of Nonclinical & Pharmaceutical Development @ Transition Therapeutics
Vice President of Nonclinical & Pharmaceutical Development
2006-01-01

tony-cruz_image

Tony Cruz
Tony Cruz Founder & Chief Executive Officer @ Transition Therapeutics
Founder & Chief Executive Officer
1998-07-01

Founder

tony-cruz_image

Tony Cruz

Stock Details

Company's stock symbol is NASDAQ:TTHI

Investors List

oracle-investment-management-inc_image

Official Site Inspections

http://www.transitiontherapeutics.com

Host Informations
Whois Informations

Unable to get host informations!!!

Loading ...